Literature DB >> 17350094

The plasmid replicon of Epstein-Barr virus: mechanistic insights into efficient, licensed, extrachromosomal replication in human cells.

Scott E Lindner1, Bill Sugden.   

Abstract

The genome of Epstein-Barr Virus (EBV) and plasmid derivatives of it are among the most efficient extrachromosomal replicons in mammalian cells. The latent origin of plasmid replication (oriP), when supplied with the viral Epstein-Barr Nuclear Antigen 1 (EBNA1) in trans, provides efficient duplication, partitioning and maintenance of plasmids bearing it. In this review, we detail what is known about the viral cis and trans elements required for plasmid replication. In addition, we describe how the cellular factors that EBV usurps are used to complement the functions of the viral constituents. Finally, we propose a model for the sequential assembly of an EBNA1-dependent origin of DNA synthesis into a pre-Replicative Complex (pre-RC), which functions by making use only of cellular enzymatic activities to carry out the replication of the viral plasmid.

Entities:  

Mesh:

Year:  2007        PMID: 17350094      PMCID: PMC2562867          DOI: 10.1016/j.plasmid.2007.01.003

Source DB:  PubMed          Journal:  Plasmid        ISSN: 0147-619X            Impact factor:   3.466


  84 in total

Review 1.  Regulation of cell growth and death by Epstein-Barr virus.

Authors:  B Wensing; P J Farrell
Journal:  Microbes Infect       Date:  2000-01       Impact factor: 2.700

Review 2.  Initiation of eukaryotic DNA replication: conservative or liberal?

Authors:  J A Bogan; D A Natale; M L Depamphilis
Journal:  J Cell Physiol       Date:  2000-08       Impact factor: 6.384

3.  The linking regions of EBNA1 are essential for its support of replication and transcription.

Authors:  D Mackey; B Sugden
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

4.  AT-hook motifs identified in a wide variety of DNA-binding proteins.

Authors:  L Aravind; D Landsman
Journal:  Nucleic Acids Res       Date:  1998-10-01       Impact factor: 16.971

5.  Rep*: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus.

Authors:  A L Kirchmaier; B Sugden
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

6.  The minimal replicator of Epstein-Barr virus oriP.

Authors:  J L Yates; S M Camiolo; J M Bashaw
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

7.  Mapping EBNA-1 domains involved in binding to metaphase chromosomes.

Authors:  V Marechal; A Dehee; R Chikhi-Brachet; T Piolot; M Coppey-Moisan; J C Nicolas
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

8.  EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance.

Authors:  K Shire; D F Ceccarelli; T M Avolio-Hunter; L Frappier
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

9.  Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: implications of the nuclear import of plasmids.

Authors:  F Längle-Rouault; V Patzel; A Benavente; M Taillez; N Silvestre; A Bompard; G Sczakiel; E Jacobs; K Rittner
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element.

Authors:  A Aiyar; C Tyree; B Sugden
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

View more
  62 in total

1.  Enhanced CHO cell-based transient gene expression with the epi-CHO expression system.

Authors:  Joe Codamo; Trent P Munro; Benjamin S Hughes; Michael Song; Peter P Gray
Journal:  Mol Biotechnol       Date:  2011-06       Impact factor: 2.695

2.  RNA-dependent recruitment of the origin recognition complex.

Authors:  Julie Norseen; Andreas Thomae; Venkatesh Sridharan; Ashok Aiyar; Aloys Schepers; Paul M Lieberman
Journal:  EMBO J       Date:  2008-10-23       Impact factor: 11.598

Review 3.  Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication.

Authors:  Emily Cousins; John Nicholas
Journal:  Recent Results Cancer Res       Date:  2014

4.  The latent origin of replication of Epstein-Barr virus directs viral genomes to active regions of the nucleus.

Authors:  Manuel J Deutsch; Elisabeth Ott; Peer Papior; Aloys Schepers
Journal:  J Virol       Date:  2009-12-23       Impact factor: 5.103

5.  E2F in vivo binding specificity: comparison of consensus versus nonconsensus binding sites.

Authors:  Alina Rabinovich; Victor X Jin; Roman Rabinovich; Xiaoqin Xu; Peggy J Farnham
Journal:  Genome Res       Date:  2008-10-03       Impact factor: 9.043

6.  Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism.

Authors:  Xiaoping Sun; Elizabeth A Barlow; Shidong Ma; Stacy R Hagemeier; Sarah J Duellman; Richard R Burgess; Judy Tellam; Rajiv Khanna; Shannon C Kenney
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-26       Impact factor: 11.205

7.  Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.

Authors:  Julianna S Deakyne; Kimberly A Malecka; Troy E Messick; Paul M Lieberman
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

8.  Epstein-Barr virus episome stability is coupled to a delay in replication timing.

Authors:  Jing Zhou; Andrew R Snyder; Paul M Lieberman
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

9.  An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions.

Authors:  Aaron Arvey; Italo Tempera; Kevin Tsai; Horng-Shen Chen; Nadezhda Tikhmyanova; Michael Klichinsky; Christina Leslie; Paul M Lieberman
Journal:  Cell Host Microbe       Date:  2012-08-16       Impact factor: 21.023

Review 10.  Targeting mitotic chromosomes: a conserved mechanism to ensure viral genome persistence.

Authors:  Katherine M Feeney; Joanna L Parish
Journal:  Proc Biol Sci       Date:  2009-01-20       Impact factor: 5.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.